Risk capital. The founder and former CEO of the somewhat controversial Human Genome Sciences, Haseltine devotes most of his time to promoting healthcare innovations in India. He picks India, friends say, as the lab for discovering "future healthcare," because all at once it has advanced technologies, sophisticated consumers, and the neediest communities in the world. India also lacks institutional barriers to change: no legacy systems or procedures, and no "installed base" of payers to stand in the way. Dr. Haseltine's foundation also seeks to nurture collaboration between art and science. A former instructor at Harvard Medical School, he is now an adjunct professor at the Scripps Institute for Medical Research, and is a correspondent in business, science and art for The Atlantic. Dr. Haseltine is also President of the William A. Haseltine Foundation for Medical Science and the Arts.